Atlas FDA

BIOSITE DIAGNOSTICS - TRIAGE PANEL FOR DRUGS OF ABUSE PLUS TRICYCLIC ANTIDEPRESSANTS

FDA 510(k) clearance K934340 · decided 1994-12-02

Clearance details

K-number
K934340
Device name
BIOSITE DIAGNOSTICS - TRIAGE PANEL FOR DRUGS OF ABUSE PLUS TRICYCLIC ANTIDEPRESSANTS
Applicant
Biosite Incorporated
Decision
Substantially Equivalent
Date received
1993-09-08
Decision date
1994-12-02
Days to decision
450 days
Clearance type
Traditional
Product code
LFI
Device class
2
Regulation number
862.3910
Medical specialty
Clinical Toxicology
Advisory committee
Clinical Toxicology
Location
San Diego, CA, US
Third-party review
No
Expedited review
No

+ Add to Predicate Builder ◉ Watch Biosite Incorporated

The Builder collects up to 8 candidate devices side by side with yours, then exports the substantial-equivalence comparison scaffold. How it works

Need this as data, not a web page?

Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.

Similar devices under this product code

Devices cleared under the same product code - the starting set for predicate research.

RecordFirmDate
BENOZODIAZEPINES AND TRICYLIC ANTIDEPRESSANTS BY HPLC (K941990)Bio-Rad1995-03-20
BENZODIAZEPINES AND TRICYCLIC ANTIDEPRESSANTS BY HPLC (K941994)Bio-Rad1995-03-20
7 TRICYCLIC ANTIDE PRESSANTS (K802245)Technicon Instruments Corp.1980-10-10

Recalls involving this device

No recalls on record reference this clearance.